In breast cancer, knockdown of lncRNA Ror led to reduced multidrug resistance-associated P-glycoprotein and GST expression, resulting in restored sensitivity of breast cancer cells to tamoxifen142. This evidence concerns the gene LINC-ROR and breast carcinoma.